UBC breakthrough opens door to $100 ultrasound machine

UBC breakthrough opens door to $100 ultrasound machine

  • September 12, 2018
Table of Contents

UBC breakthrough opens door to $100 ultrasound machine

Engineers at the University of British Columbia have developed a new ultrasound transducer, or probe, that could dramatically lower the cost of ultrasound scanners to as little as $100. Their patent-pending innovation—no bigger than a Band-Aid—is portable, wearable and can be powered by a smartphone. Conventional ultrasound scanners use piezoelectric crystals to create images of the inside of the body and send them to a computer to create sonograms.

Researchers replaced the piezoelectric crystals with tiny vibrating drums made of polymer resin, called polyCMUTs (polymer capacitive micro-machined ultrasound transducers), which are cheaper to manufacture. Sonograms produced by the UBC device were as sharp as or even more detailed than traditional sonograms produced by piezoelectric transducers, said co-author Edmond Cretu, professor of electrical and computer engineering. Co-author Robert Rohling, also a professor of electrical and computer engineering, said the next step in the research is to develop a wide range of prototypes and eventually test their device in clinical applications.

Source: ubc.ca

Share :
comments powered by Disqus

Related Posts

New anti-cancer drugs put cancers to sleep—permanently

New anti-cancer drugs put cancers to sleep—permanently

In a world first, Melbourne scientists have discovered a new type of anti-cancer drug that can put cancer cells into a permanent sleep, without the harmful side-effects caused by conventional cancer therapies. Published today in the journal Nature, the research reveals the first class of anti-cancer drugs that work by putting the cancer cell to sleep – arresting tumour growth and spread without damaging the cells’ DNA. The new class of drugs could provide an exciting alternative for people with cancer, and has already shown great promise in halting cancer progression in models of blood and liver cancers, as well as in delaying cancer relapse.

Read More
Cancer cells engineered with CRISPR slay their own kin

Cancer cells engineered with CRISPR slay their own kin

Using gene editing, scientists have hoodwinked tumor cells into turning against their own kind. Cancer cells circulating in the bloodstream have something of a homing instinct, able to find and return to the tumor where they originated. To capitalize on that ability, researchers engineered these roving tumor cells to secrete a protein that triggers a death switch in resident tumor cells they encounter.

Read More